Document is current
Any future updates will be listed below
-
Authors
Weissfuss, Chantal https://orcid.org/0000-0003-3701-3190
Li, Jingjing
Behrendt, Ulrike
Hoffmann, Karen
Bürkle, Magdalena https://orcid.org/0000-0002-4767-2942
Tan, Chunjiang
Krishnamoorthy, Gopinath
Korf, Imke H. E.
Rohde, Christine
Gaborieau, Baptiste https://orcid.org/0000-0002-9586-3014
Debarbieux, Laurent https://orcid.org/0000-0001-6875-5758
Ricard, Jean-Damien https://orcid.org/0000-0003-1828-2299
Witzenrath, Martin
Felten, Matthias
Nouailles, Geraldine https://orcid.org/0000-0003-1973-3119
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 1 May 2025
First Online: 15 May 2025
Competing interests
: M.W. received funding for research from Biotest AG, Boehringer Ingelheim, Pantherna, Vaxxilon, and for talks or advisory from Actelion, Aptarion, Astra Zeneca, Bayer Health Care, Berlin Chemie, Biotest, Boehringer Ingelheim, Chiesi, Glaxo Smith Kline, Novartis, Pantherna, Teva. G.N. received funding for research from Biotest AG. The remaining authors declare no competing interests.
